TY - JOUR
T1 - A genetic and developmental biological approach for a family with complex congenital heart diseases—evidence of digenic inheritance
AU - Yoshida, Yu
AU - Uchida, Keiko
AU - Kodo, Kazuki
AU - Ishizaki-Asami, Reina
AU - Maeda, Jun
AU - Katsumata, Yoshinori
AU - Yuasa, Shinsuke
AU - Fukuda, Keiichi
AU - Kosaki, Kenjiro
AU - Watanabe, Yusuke
AU - Nakagawa, Osamu
AU - Yamagishi, Hiroyuki
N1 - Funding Information:
This work was supported by the Japan Agency for Medical Research and Development (AMED) under grant number JP20ek0109487. KU, JM, YW, ON, and HY were supported by JSPS KAKENHI [grant numbers JP17K10153 to KU, JP19K08352 to JM, JP19H03398 to YW, JP21H02890 to ON, and JP16H05359 to HY]. YW was supported by a grant from The Japan Foundation for Pediatric Research. Acknowledgments
Funding Information:
HY receives research grants from Actelion Pharmaceuticals Japan Ltd. and Abbvie Japan Inc. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher Copyright:
2023 Yoshida, Uchida, Kodo, Ishizaki-Asami, Maeda, Katsumata, Yuasa, Fukuda, Kosaki, Watanabe, Nakagawa and Yamagishi.
PY - 2023
Y1 - 2023
N2 - Objective: Congenital heart disease (CHD) is caused by cardiovascular developmental defects and has a global prevalence of ∼1%. The etiology of CHD is multifactorial and remains generally unknown, despite advances in analytical techniques based on next-generation sequencing (NGS). The aim of our study was to elucidate the multi-genetic origin and pathogenesis of an intriguing familial case with complex CHD. Methods: We performed an original trio-based gene panel analysis using NGS of the family, including two siblings with CHD of single ventricular phenotype, and their unaffected parents. The pathogenicity of the detected rare variants was investigated in silico, and the functional effects of the variants were confirmed in vitro using luciferase assays. The combinatorial effect of gene alterations of the putative responsible genes was tested in vivo using genetically engineered mutant mice. Results: NGS-based gene panel analyses revealed two heterozygous rare variants in NODAL and in TBX20 common to the siblings and to just one of parents. Both variants were suspected pathogenic in silico, and decreased transcriptional activities of downstream signaling pathways were observed in vitro. The analyses of Nodal and Tbx20 double mutant mice demonstrated that Nodal+/−Tbx20−/− embryos showed more severe defects than Nodal+/+Tbx20−/− embryos during early heart development. The expression of Pitx2, a known downstream target of Nodal, was downregulated in Tbx20−/− mutants. Conclusions: Two rare variants on NODAL and TBX20 genes detected in this family were considered to be loss-of-function mutations. Our results suggest that NODAL and TBX20 may be complementary for the cardiac development, and a combinatorial loss-of-function of NODAL and TBX20 could be implicated in digenic inherence as the etiology of complex CHD associated with single ventricle defects in this family.
AB - Objective: Congenital heart disease (CHD) is caused by cardiovascular developmental defects and has a global prevalence of ∼1%. The etiology of CHD is multifactorial and remains generally unknown, despite advances in analytical techniques based on next-generation sequencing (NGS). The aim of our study was to elucidate the multi-genetic origin and pathogenesis of an intriguing familial case with complex CHD. Methods: We performed an original trio-based gene panel analysis using NGS of the family, including two siblings with CHD of single ventricular phenotype, and their unaffected parents. The pathogenicity of the detected rare variants was investigated in silico, and the functional effects of the variants were confirmed in vitro using luciferase assays. The combinatorial effect of gene alterations of the putative responsible genes was tested in vivo using genetically engineered mutant mice. Results: NGS-based gene panel analyses revealed two heterozygous rare variants in NODAL and in TBX20 common to the siblings and to just one of parents. Both variants were suspected pathogenic in silico, and decreased transcriptional activities of downstream signaling pathways were observed in vitro. The analyses of Nodal and Tbx20 double mutant mice demonstrated that Nodal+/−Tbx20−/− embryos showed more severe defects than Nodal+/+Tbx20−/− embryos during early heart development. The expression of Pitx2, a known downstream target of Nodal, was downregulated in Tbx20−/− mutants. Conclusions: Two rare variants on NODAL and TBX20 genes detected in this family were considered to be loss-of-function mutations. Our results suggest that NODAL and TBX20 may be complementary for the cardiac development, and a combinatorial loss-of-function of NODAL and TBX20 could be implicated in digenic inherence as the etiology of complex CHD associated with single ventricle defects in this family.
KW - complex congenital heart disease
KW - nodal
KW - rare variants
KW - tbx20
KW - trio gene analysis
UR - http://www.scopus.com/inward/record.url?scp=85158819487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85158819487&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2023.1135141
DO - 10.3389/fcvm.2023.1135141
M3 - Article
AN - SCOPUS:85158819487
SN - 2297-055X
VL - 10
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1135141
ER -